Enlivex (ENLV) Net Equity Issued and Repurchased (2013 - 2025)
Enlivex's Net Equity Issued and Repurchased was $9.83 million in Q4 2025, up 679.7% from $1.26 million a year earlier.
Powered by 
Analysis
Enlivex (ENLV) Net Equity Issued and Repurchased (2013 - 2025) Analysis & Trends
For FY2025, Net Equity Issued and Repurchased at Enlivex came in at $10.38 million, up 60.8% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $6.45 million in FY2024, $360,000 in FY2023 (+140.0%), $150,000 in FY2022 (-99.9%) and $114.16 million in FY2021 (+245.1%).
- The Q4 2025 figure marks the highest quarterly Net Equity Issued and Repurchased since Q4 2021.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last four quarters, with growth averaging 160.1%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2025 (growth of 679.7%); the worst was Q1 2022 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Enlivex | 257,041.35 | -48.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.83 Mn |
| Sep 30, 2025 | 352,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 4.42 Mn |
| Mar 31, 2024 | 524,000.00 |
| Jun 30, 2023 | 84,000.00 |
| Mar 31, 2023 | 636,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 60.87 Mn |
| Sep 30, 2021 | -7.64 Mn |
| Jun 30, 2021 | 7.70 Mn |
| Mar 31, 2021 | 53.21 Mn |
| Dec 31, 2020 | 10.53 Mn |
| Mar 31, 2020 | 22.46 Mn |
| Sep 30, 2019 | 596,000.00 |
| Jun 30, 2019 | 3.00 Mn |
API Access
Enlivex Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENLV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ENLV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENLV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();